logo
    • Magazine
    • Membership
    • Donate
  • Racial Justice
  • Economic Justice
    • Collections
  • Climate Justice
  • Health Justice
  • Leadership
  • CONTENT TYPES
  • Subscribe
  • Webinars
    • Upcoming Webinars
    • Complimentary Webinars
    • Premium On-Demand Webinars
  • Membership
  • Submissions

“Independent” Nonprofit Lobbying Groups Backed by Big Pharma Ramp-up

Ruth McCambridge and Michael Wyland
April 11, 2017
Share
Tweet
Share
Email
Print
Pixabay. Public domain. [CC 0]

April 10, 2017; The Intercept

The relationships between patient advocacy groups and big pharmaceutical companies have received a great deal of scrutiny lately. Up for question is the independence of the patient advocacy groups and the degree to which their priorities reflect the needs of patients vs. the best interests of corporations. These two sets of needs are often not in sync, but you might swear that they were when watching some of the interconnected activities.

The reach of drug companies into advocacy nonprofits extends beyond patient groups, too. The Intercept reports that this past week, as U.S. Sen. Franken’s (D-MN) Improving Access to Affordable Prescription Drugs Act gained steam, “independent” advocacy groups have placed an overwhelming number of advertisements in Beltway papers and news sites, including the Washington Post, Washington Times, Roll Call, The Hill, and Politico. The ads caution that recent proposals aimed at lowering the prices of prescription medications would have disastrous effects for patients and healthcare.

The Intercept points to the American Conservative Union (ACU), which describes itself as promoting “liberty, personal responsibility, traditional values, and strong national defense.” The full-page ad this organization placed asks, “Will government price setting lower the cost of her prescription drugs? Will government rationing increase his access to new, life-saving medicines?” Accompanying the message is a depiction of group of confused older folk.

Two advertisements come from Americans for Tax Reform (ATR), which warns against any attempt to interfere with “Part D’s protection against government interference in prescription drug pricing” and calls for retention of “free-market elements of the Medicare system.”

Sign up for our free newsletters

Subscribe to NPQ's newsletters to have our top stories delivered directly to your inbox.

By signing up, you agree to our privacy policy and terms of use, and to receive messages from NPQ and our partners.

“Keep Government Bureaucrats Out of Medicare Part D!” it heralds, not mentioning that it is funded by a nonprofit advocacy group whose financial interests are protected by the ban and, in fact, helped draft the ban.

Both nonprofits are sponsored by PhRMA, the Pharmaceutical Research and Manufacturers of America, which represents an industry group comprising Merck, Pfizer, Bristol-Myers Squibb, Purdue Pharma, and Eli Lilly. Based on review of PhRMA’s Form 990 filings, the Intercept reports that ATR received $746,000 from PhRMA between 2010 and 2014. And during the same period, ACU received $100,000.

ATR was founded by Grover Norquist, a former corporate lobbyist with a long history of using his nonprofit group to advance the interests of donors. In 2006, a congressional report found that lobbyist Jack Abramoff coordinated closely with Norquist to arrange special policy favors for his clients. In one email, Norquist requested a $50,000 donation to ATR in exchange for his group moving to oppose taxes on Brown-Forman products. The report further found that Abramoff arranged opinion columns authored by Norquist in support of Abramoff’s client goals in exchange for cash.

While there’s nothing new about coordination and collaboration between nonprofit advocacy groups seeking to influence public debate on a wide range of topics, the relationships between PhRMA and groups like ATR and ACU remind us that it’s important to know who is financing an advocacy campaign as well as who is promoting that campaign. Knowing who the players are is especially important when collaboration and cooperation between the players involves direct cash support, as cash increases the potential that a sale may have taken place.—Ruth McCambridge and Michael Wyland

Share
Tweet
Share
Email
Print
ABOUT THE AUTHORS
Ruth McCambridge

Ruth is Editor Emerita of the Nonprofit Quarterly. Her background includes forty-five years of experience in nonprofits, primarily in organizations that mix grassroots community work with policy change. Beginning in the mid-1980s, Ruth spent a decade at the Boston Foundation, developing and implementing capacity building programs and advocating for grantmaking attention to constituent involvement.

Michael Wyland

Michael L. Wyland currently serves as an editorial advisory board member and consulting editor to The Nonprofit Quarterly, with more than 400 articles published since 2012. A partner in the consulting firm of Sumption & Wyland, he has more than thirty years of experience in corporate and government public policy, management, and administration.

More about: conflicts of interest corporate givingNonprofit Newspatient advocacyPolicy

Become a member

Support independent journalism and knowledge creation for civil society. Become a member of Nonprofit Quarterly.

Members receive unlimited access to our archived and upcoming digital content. NPQ is the leading journal in the nonprofit sector written by social change experts. Gain access to our exclusive library of online courses led by thought leaders and educators providing contextualized information to help nonprofit practitioners make sense of changing conditions and improve infra-structure in their organizations.

Join Today
logo logo logo logo logo
See comments

NPQ_Winter_2022Subscribe Today
You might also like
Cancelling Student Debt Is Necessary for Racial Justice
Kitana Ananda
To Save Legal Aid, Expand Public Service Loan Forgiveness
Zoë Polk
No Justice, No Peace of Mind and Body: The Health Impacts of Housing Insecurity for Black Women
Jhumpa Bhattacharya, Maile Chand and Andrea Flynn
The Human Impact of the Global Refugee Crisis Must Be Understood—And Acted Upon
Anmol Irfan
Black Americans Need Reparations: The Fight for the CTC Highlights the Roadblocks
Jhumpa Bhattacharya and Trevor Smith
Edgar Cahn’s Second Act: Time Banking and the Return of Mutual Aid
Steve Dubb

Upcoming Webinars

Remaking the Economy

Black Food Sovereignty, Community Stories

Register Now
You might also like
Cancelling Student Debt Is Necessary for Racial Justice
Kitana Ananda
To Save Legal Aid, Expand Public Service Loan Forgiveness
Zoë Polk
No Justice, No Peace of Mind and Body: The Health Impacts of...
Jhumpa Bhattacharya, Maile Chand and Andrea Flynn

Like what you see?

Subscribe to the NPQ newsletter to have our top stories delivered directly to your inbox.

See our newsletters

By signing up, you agree to our privacy policy and terms of use, and to receive messages from NPQ and our partners.

Independent & in your mailbox.

Subscribe today and get a full year of NPQ for just $59.

subscribe
  • About
  • Contact
  • Advertise
  • Copyright
  • Careers

We are using cookies to give you the best experience on our website.

 

Non Profit News | Nonprofit Quarterly
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.